The new statistical report titled as Gene Therapy Market has recently published by Absolute
Markets Insights. This study comprises mix data containing the recent trends,
technological platforms, tools, and certain methodologies. It gives an overview
of the market dynamics such as the changing needs of the clients in different
regions. This research report offers a comprehensive analysis of different
parameters of businesses like profit margin, shares and pricing structures. It
has been compiled by using qualitative and quantitative analysis techniques.
The valuable insights of businesses have been examined by using primary and
secondary research methodologies in a particular manner.
A section containing the data about
different factors influencing the progress of the Gene Therapy market. This
research report offers a bird’s eye view on the historical as well as current
trends operating in the global Gene Therapy market. Different market segment
and its sub-segment have been elaborated to understand the market clearly.
Leading key players have been profiled to get detailed data about company
profiles, contact details, and revenue of the companies.
Top Key
Players includes:
Voyager Therapeutics, Inc., Spark Therapeutics, Inc., Sangamo Therapeutics,
Human Stem Cells Institute PJSC, Orchard Therapeutics plc, Genenta Science,
Chiesi Farmaceutici S.p.A., Novartis AG, GlaxoSmithKline PLC, Gilead Sciences,
Inc., Bristol - Myers Squibb Delta Company Limited, Advanced Cell & Gene
Therapy, LLC, Audentes Therapeutics, Inc., Biogen, and Pfizer Inc. amongst
other
For More
Information Click@ https://www.absolutemarketsinsights.com/reports/Gene-Therapy-Market-2019-2027-308
Objective of this Report:
- In
terms of revenue, global gene therapy market is expected to reach US$
5609.9+ million by 2030 owing to government support for the development of
gene therapy techniques to deal with fatal diseases. Somatic Gene Therapy
held the largest market share in 2018 and is expected to grow at a CAGR of
over +66% during the forecast period due to development of many disorders,
including cystic fibrosis, muscular dystrophy, cancer and certain
infectious diseases.
- Asia
Pacific region is expected to witness the highest CAGR over the forecast
period owing to increasing investment in research and development and
improvement of healthcare infrastructure.
Gene Therapy Market
Segmentation:
By Type
- Germ
Line Gene Therapy
- Somatic
Gene Therapy
- Ex
Vivo Gene Therapy
- In
Vivo Gene Therapy
By Therapy Area:
- Cancer
- Infectious
Diseases
- Rheumatoid
Arthritis
- Genetic
Disorders
- Neurological
Disorders
- Others
By Vector Type:
- Viral
Vectors
- Adenoviruses
- Retroviruses
- Alphaviruses
- Adeno-
Associated Virus
- Herpes
Simplex Virus
- Vaccinia
Viruses
- Others
(Lentivirus, Vaccinia Virus, Etc.)
- Non-Viral
Vectors
- Naked
DNA
- Oligonucleotides
- Lipoplexes
and Polyplexes
- Human
Artificial Chromosome
By Region
- North
America
- Europe
- Asia
Pacific
- Middle
East and Africa
- Latin
America
Why Buy this Report?
·
Extensive analysis on latest trends and growth opportunities
in different regions across the globe
·
Comprehensive assessment on recent technological
advancements and forecast of the upcoming period
·
A comparative analysis of leading players and
emerging players in the Gene Therapy market
·
Authentic information on new product launches,
organic and inorganic strategies, and more
·
Valuable insights on the impact of regulatory
framework on the global Gene Therapy market
Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com
No comments:
Post a Comment